Developer docs
API playgroundTry for free, no card

Search company profiles

Ki Tua Fund

Full company profile

uuid0006n7a

Namestring
Ki Tua Fund
Legal namestring
Ki Tua Fund
Websiteurl
kituafund.com
Company typeenum
Private
Founded yearstring
-
Descriptiontext

Ki Tua Fund is the corporate venture capital arm of Fonterra Co-operative Group Limited, a New Zealand-based dairy cooperative. The fund invests in, partners with, and supports innovative early-stage startups developing disruptive solutions at the intersection of science, nutrition, and technology, with a stated focus on positive health impact. Its portfolio spans precision fermentation, photomolecular biomanufacturing, microbiome therapeutics, and agricultural productivity, including positions in Prolific Machines, Kanvas Biosciences, Fermeate, and BioLumic.

The fund's core offering combines flexible financial capital (including lead and follow-on investments) with strategic non-financial value: access to Fonterra's nearly 100 years of manufacturing and distribution expertise, scientific and technical due diligence support, clinical trial and commercialization experience, and a global commercial network. It operates as a standalone entity with headquarters in Auckland and Managing Director-led offices in Amsterdam (Europe deal flow) and San Francisco (USA deal flow), staffed by 51-100 employees including investment managers, partners, board members, and external scientific advisors.

Ki Tua Fund generates returns primarily through equity appreciation in portfolio companies rather than fee-based revenue, consistent with corporate venture capital structures. Its go-to-market is founder-first and relationship-driven, sourcing deals via direct outreach, partner referrals, industry conferences, and digital channels. The fund serves food and nutrition technology startups, health and biotechnology ventures, and agricultural innovation companies, with the implicit strategic objective of contributing to Fonterra's innovation pipeline alongside financial return.

Short descriptiontext

Ki Tua Fund is the corporate venture capital arm of Fonterra Co-operative Group, investing in and partnering with early-stage food, nutrition, health technology, and agricultural startups globally. The fund provides flexible capital alongside access to Fonterra's scientific, manufacturing, and distribution expertise, operating from New Zealand with offices in Amsterdam and San Francisco.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersAuckland, New Zealand
HQ citystring
Auckland
HQ countrystring
New Zealand
HQ regionstring
Oceania
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
venture capital fund, corporate venture capital, food tech investment, agtech investment, health technology investing
Industry2 codes
1Micro-PE / Lower Middle Market ETA Funds
CodeFSANALAGPrimaryYes
2Core Infrastructure Funds (Transport, Social, Digital, Utilities)
CodeFSANAEAAPrimaryNo
NAICS code2 codes
  • Pension Funds525110
  • Other Investment Pools and Funds5259
SIC code2 codes
  • Investors, Nec6799
  • Finance Services6199
Product category
Venture Capital
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Investment Returns
TypeLicensing Royalties
Description

Ki Tua Fund generates returns through equity investments in portfolio companies. As the corporate venture arm of Fonterra, they also seek strategic value through partnerships that can contribute to Fonterra's innovation and growth objectives.

kituafund.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Ki Tua Fund is the corporate venture capital arm of Fonterra Co-operative Group that invests in and partners with early-to-growth-stage start-ups developing disruptive solutions combining science, nutrition, and technology for positive health impact. The fund provides flexible capital investment (including lead and follow-on funding), access to technical and scientific expertise, and entry into Fonterra's global commercial, manufacturing, and distribution network spanning nearly 100 years of operational experience.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Ki Tua Fund is a corporate venture arm of Fonterra Co-operative Group that operates as an investment fund focused on food, nutrition, and health technology start-ups. The fund provides a combination of financial investment, technical expertise, and global network access to support portfolio companies. Rather than offering a unified software product with distinct modules, Ki Tua Fund functions as a strategic investment vehicle that brings nearly 100 years of Fonterra's manufacturing and distribution experience to early-stage companies developing disruptive solutions in health and nutrition.

Product and service3 records
1Financial Investment (Equity Capital)
CategoryVenture Capital
Description

Flexible equity capital investment offered to innovative start-ups in food, nutrition, and health technology sectors, including lead and follow-on funding across seed through Series B rounds.

2Technical Expertise Access
CategoryVenture Capital Advisory
Description

Provides portfolio companies with access to strong technical expertise across science, nutrition, and technology, along with clinical trial and commercialization experience through the fund's team and the broader Fonterra network.

3Global Network and Commercial Reach
CategoryVenture Capital Advisory
Description

Connects founders, companies, and partners into the breadth and depth of Fonterra's commercial capability, investment ecosystem, and global distribution network spanning nearly 100 years of operational experience.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Venture capital platform specializing in agrifood tech. Emerging player with broader, more diversified portfolio construction across food and agriculture categories.

TypeDirect peer
Description

Chicago-based venture capital firm investing in food, agriculture, and ocean technology. Direct peer as a strategic food/ag VC fund with comparable thesis and stage focus to Ki Tua Fund.

TypeDirect peer
Description

Multi-stage venture fund and accelerator operator (IndieBio, HAX). Direct peer as an active co-investor in Ki Tua portfolio companies (Prolific Machines, Fermeate) with deep biotech accelerator expertise.

TypeDirect peer
Description

Food and agriculture venture capital fund focused on sustainability and health outcomes. Direct peer with similar food-system transformation thesis.

TypeDirect peer
Description

Venture fund investing in agrifood technology. Direct peer given shared focus on agrifood innovation and similar stage deployment.

TypeDirect peer
Description

Specialized food and agriculture technology venture fund. Direct peer given shared food-tech investment mandate and early-to-growth stage focus.

TypeDirect peer
Description

Corporate venture arm of Cargill focused on food and agriculture innovation. Direct peer as a food/ag CVC; Rachel Resek, Ki Tua's USA MD, previously held investing roles there.

TypeDirect peer
Description

Bayer's venture arm focused on health and agriculture breakthroughs. Direct peer as a strategic CVC with health/nutrition overlap; Rachel Resek previously worked there.

TypeDirect peer
Description

Venture capital firm focused on agricultural technology. Direct peer in the food/ag-tech VC landscape with comparable early-stage investment thesis.

TypeDirect peer
Description

Corporate venture arm of Syngenta focused on agricultural innovation. Direct peer as an ag-input CVC operating at the intersection of agriscience and biotech.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles13 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment5 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Ki Tua Fund

Venture Capitalkituafund.com

Ki Tua Fund is the corporate venture capital arm of Fonterra Co-operative Group, investing in and partnering with early-stage food, nutrition, health technology, and agricultural startups globally. The fund provides flexible capital alongside access to Fonterra's scientific, manufacturing, and distribution expertise, operating from New Zealand with offices in Amsterdam and San Francisco.

What Ki Tua Fund does

Ki Tua Fund is the corporate venture capital arm of Fonterra Co-operative Group Limited, a New Zealand-based dairy cooperative. The fund invests in, partners with, and supports innovative early-stage startups developing disruptive solutions at the intersection of science, nutrition, and technology, with a stated focus on positive health impact. Its portfolio spans precision fermentation, photomolecular biomanufacturing, microbiome therapeutics, and agricultural productivity, including positions in Prolific Machines, Kanvas Biosciences, Fermeate, and BioLumic.

The fund's core offering combines flexible financial capital (including lead and follow-on investments) with strategic non-financial value: access to Fonterra's nearly 100 years of manufacturing and distribution expertise, scientific and technical due diligence support, clinical trial and commercialization experience, and a global commercial network. It operates as a standalone entity with headquarters in Auckland and Managing Director-led offices in Amsterdam (Europe deal flow) and San Francisco (USA deal flow), staffed by 51-100 employees including investment managers, partners, board members, and external scientific advisors.

Ki Tua Fund generates returns primarily through equity appreciation in portfolio companies rather than fee-based revenue, consistent with corporate venture capital structures. Its go-to-market is founder-first and relationship-driven, sourcing deals via direct outreach, partner referrals, industry conferences, and digital channels. The fund serves food and nutrition technology startups, health and biotechnology ventures, and agricultural innovation companies, with the implicit strategic objective of contributing to Fonterra's innovation pipeline alongside financial return.

Ki Tua Fund firmographics

Firmographics
Name
Ki Tua Fund
Legal name
Ki Tua Fund
Website
https://kituafund.com
Company type
Private
Operating status
Operating
Headcount range
51–100 employees
Short description
Ki Tua Fund is the corporate venture capital arm of Fonterra Co-operative Group, investing in and partnering with early-stage food, nutrition, health technology, and agricultural startups globally. The fund provides flexible capital alongside access to Fonterra's scientific, manufacturing, and distribution expertise, operating from New Zealand with offices in Amsterdam and San Francisco.
Ownership category
akta.pro rank

Ki Tua Fund industry classification

Industry
Product category
Venture Capital
NAICS
Pension Funds (525110), Other Investment Pools and Funds (5259)
SIC
Investors, Nec (6799), Finance Services (6199)
akta.pro primary industry
Micro-PE / Lower Middle Market ETA Funds (FSANALAG)
akta.pro secondary industry
Core Infrastructure Funds (Transport, Social, Digital, Utilities) (FSANAEAA)

Keywords

  • Venture capital fund
  • Corporate venture capital
  • Food tech investment
  • Agtech investment
  • Health technology investing

Where Ki Tua Fund is headquartered

Location

Headquarters

HQ city
Auckland
HQ country
New Zealand
HQ region
Oceania

Offices3 records

Markets served

Ki Tua Fund business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

  1. Investment Returns: Ki Tua Fund generates returns through equity investments in portfolio companies. As the corporate venture arm of Fonterra, they also seek strategic value through partnerships that can contribute to Fonterra's innovation and growth objectives.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Ki Tua Fund product offering

Product offering

Core offering

Ki Tua Fund is the corporate venture capital arm of Fonterra Co-operative Group that invests in and partners with early-to-growth-stage start-ups developing disruptive solutions combining science, nutrition, and technology for positive health impact. The fund provides flexible capital investment (including lead and follow-on funding), access to technical and scientific expertise, and entry into Fonterra's global commercial, manufacturing, and distribution network spanning nearly 100 years of operational experience.

Product overview

Ki Tua Fund is a corporate venture arm of Fonterra Co-operative Group that operates as an investment fund focused on food, nutrition, and health technology start-ups. The fund provides a combination of financial investment, technical expertise, and global network access to support portfolio companies. Rather than offering a unified software product with distinct modules, Ki Tua Fund functions as a strategic investment vehicle that brings nearly 100 years of Fonterra's manufacturing and distribution experience to early-stage companies developing disruptive solutions in health and nutrition.

Differentiator

Problem solved

Functional benefit

Products and services

  • Financial Investment (Equity Capital) Flexible equity capital investment offered to innovative start-ups in food, nutrition, and health technology sectors, including lead and follow-on funding across seed through Series B rounds.
  • Technical Expertise Access Provides portfolio companies with access to strong technical expertise across science, nutrition, and technology, along with clinical trial and commercialization experience through the fund's team and the broader Fonterra network.
  • Global Network and Commercial Reach Connects founders, companies, and partners into the breadth and depth of Fonterra's commercial capability, investment ecosystem, and global distribution network spanning nearly 100 years of operational experience.

Companies that use Ki Tua Fund

Customer profile

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Ki Tua Fund technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Ki Tua Fund partnerships and signals

Strategic signal

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Ki Tua Fund competitors and assessment

Company assessment

Emerging players

  • AgFunder: Venture capital platform specializing in agrifood tech. Emerging player with broader, more diversified portfolio construction across food and agriculture categories.

Direct peers

  • S2G Ventures: Chicago-based venture capital firm investing in food, agriculture, and ocean technology. Direct peer as a strategic food/ag VC fund with comparable thesis and stage focus to Ki Tua Fund.
  • SOSV: Multi-stage venture fund and accelerator operator (IndieBio, HAX). Direct peer as an active co-investor in Ki Tua portfolio companies (Prolific Machines, Fermeate) with deep biotech accelerator expertise.
  • Acre Venture Partners: Food and agriculture venture capital fund focused on sustainability and health outcomes. Direct peer with similar food-system transformation thesis.
  • Cultivian Sandbox Ventures: Venture fund investing in agrifood technology. Direct peer given shared focus on agrifood innovation and similar stage deployment.
  • Pontifax AgTech: Specialized food and agriculture technology venture fund. Direct peer given shared food-tech investment mandate and early-to-growth stage focus.
  • Cargill Ventures: Corporate venture arm of Cargill focused on food and agriculture innovation. Direct peer as a food/ag CVC; Rachel Resek, Ki Tua's USA MD, previously held investing roles there.
  • Leaps by Bayer: Bayer's venture arm focused on health and agriculture breakthroughs. Direct peer as a strategic CVC with health/nutrition overlap; Rachel Resek previously worked there.
  • Fall Line Capital: Venture capital firm focused on agricultural technology. Direct peer in the food/ag-tech VC landscape with comparable early-stage investment thesis.
  • Syngenta Group Ventures: Corporate venture arm of Syngenta focused on agricultural innovation. Direct peer as an ag-input CVC operating at the intersection of agriscience and biotech.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Ki Tua Fund social profiles

Digital presence

Ki Tua Fund financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Ki Tua Fund leadership team

Management profile

Number of profiles

Profiles13 records

Ki Tua Fund funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Ki Tua Fund M&A and investment

M&A and investment

M&A

Investments5 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ki Tua Fund

What does Ki Tua Fund do?

Ki Tua Fund is the corporate venture capital arm of Fonterra Co-operative Group that invests in and partners with early-to-growth-stage start-ups developing disruptive solutions combining science, nutrition, and technology for positive health impact. The fund provides flexible capital investment (including lead and follow-on funding), access to technical and scientific expertise, and entry into Fonterra's global commercial, manufacturing, and distribution network spanning nearly 100 years of operational experience.

Is Ki Tua Fund a public or private company?

Ki Tua Fund is a private company. It is classified as corporate owned and is currently operating.

When was Ki Tua Fund founded?

Ki Tua Fund was founded in -1. It employs 51 to 100 people.

Where is Ki Tua Fund based?

Ki Tua Fund is headquartered in Auckland, New Zealand, in the Oceania region.

How does Ki Tua Fund make money?

One revenue line is on record: investment Returns.

Who are Ki Tua Fund's main competitors?

AgFunder is listed as an emerging player. Direct peers are S2G Ventures, SOSV, Acre Venture Partners, Cultivian Sandbox Ventures, Pontifax AgTech, Cargill Ventures, Leaps by Bayer, Fall Line Capital and Syngenta Group Ventures.

Does Ki Tua Fund have an API?

No public API is recorded for Ki Tua Fund.

What industry is Ki Tua Fund in?

Ki Tua Fund's product category is Venture Capital. Its primary akta.pro industry code is FSANALAG, Micro-PE / Lower Middle Market ETA Funds, with a secondary code of FSANAEAA, Core Infrastructure Funds (Transport, Social, Digital, Utilities). Its NAICS code is 525110 and its SIC code is 6799.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Venture Capital Access OnlineKanvas Biosciences Secures $48M Series A to Deliver Novel Microbiome Therapeutics to Cancer PatientsKanvas Biosciences raised $48 million in a Series A co-led by DCVC and Lions Capital, with Gates Foundation participating. The funds will advance clinical trials for its lead immuno-oncology drug KAN-001, which targets cancer patients unresponsive to checkpoint inhibitors. The company also plans to launch its own clinical trials and operate a new GMP manufacturing suite.FinSMEsKanvas Biosciences Raises $48M in Series A FundingKanvas Biosciences raised $48M in Series A funding led by DCVC and Lions Capital. The company will use the funds to conduct clinical trials for its immuno-oncology candidate KAN-001 and advance commercial partnerships. The spatial biology company aims to develop live biotherapeutics for microbiome-associated diseases.Venture Capital Access OnlineFermeate Raises $2M Seed to Improve Fermentation with LightFermeate raised $2 million in seed funding led by Newfund Capital to develop light-based optogenetic control for industrial fermentation. The company claims its technology improves fermentation outputs by 60-300% and converts existing fermenters at less than 5% the cost of new tanks.BiolumicBioLumic Oversubscribed Funding Round Accelerates a New Category of Non-GMO Seed Traits — BIOLUMICBioLumic Inc. has announced the closure of its oversubscribed Series B Extension funding round, securing $8.3 million from investors including Ki Tua Fund, Azolla Ventures, and iSelect Fund to advance its new category of seed traits known as xTraits™. The funding will support the rollout of innovations that enhance seed traits, improving yield, stress resilience, and nutritional composition while dramatically reducing development time and costs. BioLumic aims to capture 10% of the non-transgenic seed trait market within five years through this breakthrough technology and its commercial partnerships.OurCrowdBioLumic oversubscribed funding round accelerates a new category of non-GMO seed traitsBioLumic Inc. closed an oversubscribed $8.3 million Series B Extension funding round led by Ki Tua Fund, Azolla Ventures, and iSelect Fund to accelerate the commercialization of its xTraits™ light-activated seed technology. The company has launched its first commercial activation system at Gro Alliance’s facility in the U.S., with field trials showing over 20% yield gains in hybrid corn for the 2026 planting season.YahooBioLumic Oversubscribed Funding Round Accelerates a New Category of Non-GMO Seed TraitsBioLumic closed an oversubscribed $8.3M Series B Extension from new and existing investors, including Ki Tua Fund, Azolla Ventures, and iSelect Fund. The capital will accelerate commercialization of its xTraits light-activated seed traits in corn, rice, soybean, and forage, with a goal of capturing 10% of the non-transgenic seed trait market within five years.NimblesciNEW FUNDING: Small Intestinal Data has the Potential to Revolutionize Gut Health Product InnovationNimble Science, a Calgary-based digital health company, announced new capital injection from Ki Tua Fund, the venture capital arm of Fonterra Co-operative Group, to accelerate commercialization of its SIMBA capsule platform for collecting multi-omic microbiome data from the small intestine. The funding follows a prior investment by Seventure Partners and adds to the $2 million seed round led by Fusion Fund in 2023. The company will use the funds to expand its end-to-end GI intelligence platform serving pharmaceutical, diagnostics, and consumer wellness industries worldwide.